This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Stocks Attempt Rally on Hope for Upbeat Earnings, Unlikely to Last for Long
by Mayur Thaker
Market may be due for a breather, but primary trend indicates lower
Will UnitedHealth Group (UNH) Beat Q3 Earnings Estimates?
by Zacks Equity Research
UnitedHealth Group's (UNH) third-quarter results are likely to benefit from higher premiums and membership growth in its UnitedHealthcare unit, partly offset by elevated technology investment costs.
Dow ETFs in Focus Ahead of Q3 Earnings
by Sweta Killa
After the worst first nine months of 2022, the Dow Jones Industrial Average showed some stability at the start of the fourth quarter.
UnitedHealth Group (UNH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $498.86, marking a -1.19% move from the previous day.
Wall Street Waits for Q3 2022 Earnings to Kick Off
by Zacks Equity Research
Wall Street Waits for Q3 2022 Earnings to Kick Off.
Big Week for Data, Earnings Starts Quiet
by Mark Vickery
The big news for the week will be along two paths: CPI data for September and the start of Q3 earnings season.
UnitedHealth Group (UNH) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
UnitedHealth (UNH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Trending Stock UnitedHealth Group Incorporated (UNH) a Buy Now?
by Zacks Equity Research
UnitedHealth (UNH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is SPDR MSCI USA StrategicFactors ETF (QUS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QUS
Zacks Market Edge Highlights: ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA
by Zacks Equity Research
ExxonMobil, Meta Platforms, UnitedHealth Group, Biogen and NVIDIA are part of the Zacks Market Edge article.
Should You Sell Your FANGMAN Stocks?
by Tracey Ryniec
Tracey and Kevin discuss the rocky 2022 stock market and the future of growth stocks.
UnitedHealth (UNH) Grows on Optum Strength, Cost Woes Stay
by Zacks Equity Research
UnitedHealth's (UNH) health service business, Optum, is becoming increasingly valuable and is crucial to the company's diversification strategy.
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, UnitedHealth Group (UNH) closed at $523.17, marking a +1.49% move from the previous day.
Why UnitedHealth (UNH) Could Beat Earnings Estimates Again
by Zacks Equity Research
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cigna's (CI) New Pathwell Suite to Boost Efficiency, Lower Cost
by Zacks Equity Research
Cigna (CI) expects to bump up its Pathwell suite's availability throughout the next year.
Is Vanguard Dividend Appreciation ETF (VIG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for VIG
How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Should Vanguard Value ETF (VTV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VTV
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
UnitedHealth Group (UNH) closed at $513.94 in the latest trading session, marking a +1.1% move from the prior day.
Molina Healthcare (MOH) Wins Medicaid Deal From Nebraska DHHS
by Zacks Equity Research
Molina Healthcare (MOH) clinches a contract from the Nebraska DHHS, through which the health insurer can efficiently serve the state's Medicaid members and boost its statewide presence.
Centene's (CNC) Contract Win to Aid Nebraska's Medicaid Members
by Zacks Equity Research
The Nebraska DHHS awards a contract to Centene's (CNC) Nebraska arm to continue serving the unmet need of the state's Medicaid members with a suite of better healthcare options.
UnitedHealth (UNH) Wins New Medicaid Contract in Nebraska
by Zacks Equity Research
UnitedHealth's (UNH) UnitedHealthcare boasts a network of 100 hospitals and more than 14,000 physicians and caregivers in Nebraska.
The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Chevron, The Home Depot and AT&T
by Zacks Equity Research
UnitedHealth Group, Johnson & Johnson, Chevron, The Home Depot and AT&T are part of the Zacks top Analyst Blog.
Zacks Industry Outlook Highlights UnitedHealth Group, Humana, Centene and Molina Healthcare
by Zacks Equity Research
UnitedHealth Group, Humana, Centene and Molina Healthcare are part of Zacks Industry Outlook article.